Diabetic retinopathy screening and treatment through the Brazilian National Health Insurance
- PMID: 35977971
- PMCID: PMC9385734
- DOI: 10.1038/s41598-022-18054-6
Diabetic retinopathy screening and treatment through the Brazilian National Health Insurance
Abstract
The current study aimed to investigate diabetic retinopathy (DR) screening and treatment coverages among diabetic patients evaluated through the Brazilian National Health Insurance from 2014 to 2019. The Brazilian Public Health System Information Database was used as the primary data source. DR screening coverage was calculated as the rate of procedures of clinical dilated fundus exam and color fundus photograph over the number of diabetic patients. DR treatment coverage was calculated as the rate of procedures of intravitreal injection, photocoagulation, and panretinal photocoagulation over the number of diabetic patients presumably in need of DR treatment. The overall screening coverage increased from 12.1% in 2014 to 21.2% in 2019 (p < 0.001) with substantial regional discrepancies so that North region was the only one with no changes along the period. The overall treatment coverage increased from 27.7% in 2014 to 44.1% in 2019, with Southeast and Midwest absorbing the demand for service from the North, Northeast and South. Despite an improvement along the past years, both screening and treatment coverages for DR in diabetes patients are ineffective in Brazil. Public health policies should address resources disparities throughout the country aiming to offer same healthcare conditions to patients regardless their geographic location.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Trends in Diabetic Retinopathy, Visual Acuity, and Treatment Outcomes for Patients Living With Diabetes in a Fundus Photograph-Based Diabetic Retinopathy Screening Program in Bangladesh.JAMA Netw Open. 2019 Nov 1;2(11):e1916285. doi: 10.1001/jamanetworkopen.2019.16285. JAMA Netw Open. 2019. PMID: 31774523 Free PMC article.
-
[Screening for diabetic retinopathy by non-mydriatic fundus photography: First national campaign in Lebanon].J Fr Ophtalmol. 2019 Mar;42(3):288-294. doi: 10.1016/j.jfo.2018.12.005. Epub 2019 Mar 8. J Fr Ophtalmol. 2019. PMID: 30857804 French.
-
Diabetic Retinopathy and Related Clinical Practice for People with Diabetes in Korea: A 10-Year Trend Analysis.Diabetes Metab J. 2020 Dec;44(6):928-932. doi: 10.4093/dmj.2020.0096. Epub 2020 Jul 10. Diabetes Metab J. 2020. PMID: 32662253 Free PMC article.
-
Diabetic Retinopathy in Italy: Epidemiology Data and Telemedicine Screening Programs.J Diabetes Res. 2016;2016:3627465. doi: 10.1155/2016/3627465. Epub 2016 Nov 21. J Diabetes Res. 2016. PMID: 27990441 Free PMC article. Review.
-
Diabetic Retinopathy in the Asia-Pacific.Asia Pac J Ophthalmol (Phila). 2018 Jan-Feb;7(1):3-16. doi: 10.22608/APO.2017511. Epub 2017 Jan 26. Asia Pac J Ophthalmol (Phila). 2018. PMID: 29376231 Review.
Cited by
-
The use of social simulation modelling to understand adherence to diabetic retinopathy screening programs.Sci Rep. 2024 Feb 29;14(1):4963. doi: 10.1038/s41598-024-55517-4. Sci Rep. 2024. PMID: 38424187 Free PMC article.
-
Artificial intelligence for diabetic retinopathy screening: beyond diagnostic accuracy.Ann Transl Med. 2022 Oct;10(20):1080. doi: 10.21037/atm-22-4756. Ann Transl Med. 2022. PMID: 36388776 Free PMC article. No abstract available.
-
Improving diabetic retinopathy screening at the point of care: integrating telemedicine to overcome current challenges.BMC Ophthalmol. 2024 Jun 14;24(1):256. doi: 10.1186/s12886-024-03508-4. BMC Ophthalmol. 2024. PMID: 38877501 Free PMC article.
-
Prevalence of diabetic retinopathy in Brazil: a systematic review with meta-analysis.Diabetol Metab Syndr. 2023 Mar 2;15(1):34. doi: 10.1186/s13098-023-01003-2. Diabetol Metab Syndr. 2023. PMID: 36864478 Free PMC article.
-
Contributions and future potential of animal models for geroscience research on sensory systems.Geroscience. 2025 Feb;47(1):61-83. doi: 10.1007/s11357-024-01327-5. Epub 2024 Sep 23. Geroscience. 2025. PMID: 39312151 Free PMC article. Review.
References
-
- GBD Blindness and Vision Impairment Collaborators. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob. Health. 2019;9:e144–e160. - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous